Exagen Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
/
Date30 Oct 2018
Email Print Friendly Share Albuquerque, NM and San Diego, CA, Oct. 30, 2018 (GLOBE NEWSWIRE) — Exagen Diagnostics, a leader in autoimmune life sciences, today... Read More →
PINTEC Announces Pricing of Initial Public Offering
/
Date29 Oct 2018
Email Print Friendly Share BEIJING, Oct. 25, 2018 (GLOBE NEWSWIRE) — Pintec Technology Holdings Limited (NASDAQ: PT) (“PINTEC” or the “Company”), a leading independent technology... Read More →
ChaSerg Technology Acquisition Corp. Announces Closing of Underwriter’s Over-Allotment Option in Connection with its Initial Public Offering
/
Date28 Oct 2018
Email Print Friendly Share New York, NY, Oct. 25, 2018 (GLOBE NEWSWIRE) — ChaSerg Technology Acquisition Corp. (NASDAQ: CTACU) (the “Company”) announced today that it... Read More →
Plus Products Inc. Completes CAD$20 Million Initial Public Offering
/
Date27 Oct 2018
Email Print Friendly Share SAN MATEO, Calif., Oct. 26, 2018 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (the “Company”) is pleased to announce the... Read More →
County Capital One Ltd. Completes Initial Public Offering and Lists on the TSX Venture Exchange
/
Date26 Oct 2018
Email Print Friendly Share TORONTO, Oct. 26, 2018 (GLOBE NEWSWIRE) — County Capital One Ltd. (the “Corporation”) (TSX-V: CCAP.P) is pleased to announce that it... Read More →
StoneCo Ltd. Announces Pricing of Initial Public Offering
/
Date25 Oct 2018
SÃO PAULO, Brazil, Oct. 25, 2018 (GLOBE NEWSWIRE) — StoneCo Ltd. (“Stone”) today announced the pricing of its initial public offering of 50,724,638 shares of its... Read More →
LogicBio Therapeutics Announces Closing of Initial Public Offering
/
Date24 Oct 2018
Email Print Friendly Share CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to... Read More →
PhaseBio Announces Pricing of Initial Public Offering
/
Date23 Oct 2018
Email Print Friendly Share MALVERN, Pa. and SAN DIEGO, Oct. 17, 2018 (GLOBE NEWSWIRE) — PhaseBio Pharmaceuticals, Inc. (“PhaseBio”), a clinical-stage biopharmaceutical company focused on... Read More →
Osmotica Pharmaceuticals plc Announces Pricing of Initial Public Offering
/
Date22 Oct 2018
Email Print Friendly Share BRIDGEWATER, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the pricing of... Read More →
Niu Technologies Announces Pricing of Initial Public Offering
/
Date21 Oct 2018
Email Print Friendly Share BEIJING, Oct. 18, 2018 (GLOBE NEWSWIRE) — Niu Technologies (“Niu” or “the Company”), the world’s leading provider of smart urban mobility... Read More →